HLIT vs NVDA

HLIT exhibits a stable but mediocre Piotroski F-Score of 4/9, while deterministic value metrics (Graham Number $0.88, Intrinsic Value $0.07) suggest the stock is severely overvalued at its current price of $9.75. The company is facing a catastrophic collapse in growth, with YoY revenue down 55.8% and Q/Q revenue down 123.87%. While the balance sheet remains healthy with a low Debt/Equity ratio of 0.35 and a strong Current Ratio of 2.50, the fundamental disconnect between price and performance is extreme. The market appears to be pricing in a recovery based on a Forward P/E of 13.43, but current data shows a trailing P/E of 975 and negative profit margins.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.